VCYT
VERACYTE, INC.
VERACYTE, INC. (VCYT) has 16 SEC Form 4 filings (25 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jun 22, 2026.
Insiders have net sold $9.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Marc A. Stapley
- Employees:824
- HQ:South San Francisco, CA, US
- IPO:2013-10-30
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.2M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$4.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
EASTHAM KARINFirst filing | Director | Sale | 3,729 | $197K | Jun 22 | SEC ↗ |
McGuire AnnieFirst filing | EVP, General Counsel | Sale | 3,176 | $158K | Jun 5 | SEC ↗ |
Chambers RebeccaFirst filing | Chief Financial Officer | Sale | 3,561 | $177K | Jun 5 | SEC ↗ |
Stapley MarcFirst filing | Chief Executive Officer | Sale | 138,051 | $6.9M | Jun 5 | SEC ↗ |
Leite JohnFirst filing | Global Chief Commercial Off | Sale | 13,975 | $700K | Jun 5 | SEC ↗ |
Wygant JonathanFirst filing | VP, Chief Accounting Officer | Sale | 24,000 | $1.1M | May 27 | SEC ↗ |
Related companies
VERACYTE, INC. is in the Healthcare sector.